Protalix BioTherapeutics
PLX
#8625
Rank
NZ$0.22 B
Marketcap
$3.11
Share price
1.15%
Change (1 day)
12.58%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2023 (TTM): $0.17

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is $0.18. In 2022 the company made an earnings per share (EPS) of -$0.53 an increase over its 2021 EPS that were of -$1.10.

EPS history for Protalix BioTherapeutics from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.17-131.31%
2022-$0.53-51.61%
2021-$1.10342.86%
2020-$0.25-88.71%
2019-$2.19-34.74%
2018-$3.36-70.92%
2017-$11.552153.35%
2016-$0.51-146.77%
2015$1.10-287.88%
2014-$0.5810%
2013-$0.53130.77%
2012-$0.23-56.67%
2011-$0.53-46.43%
2010-$0.9936.59%
2009-$0.7232.26%
2008-$0.55-93.4%
2007-$8.311298.53%
2006-$0.59-96.59%
2005-$17.4319.32%
2004-$14.611552.65%
2003-$0.88-0%
2002-$0.88-50%
2001-$1.77233.33%
2000-$0.53-84.21%
1999-$3.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.13-740.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.47 1,860.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.29 1,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.54-2,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel